Hormonal regulation of catechol-O-methyl transferase activity in women with uterine leiomyomas

Fertility and Sterility

Volumn 86, Issue 1, 2006, Pages 259-262

  Salama, Salama A ^a   Ho, Shu Leong ^b   Wang, Hui Qun ^c   Tenhunen, Jukka ^d   Tilgmann, Carola ^d   Al Hendy, Ayman ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d ORION CORPORATION   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DEXAMETHASONE; ESTROGEN; PROGESTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME RELEASE; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN TISSUE; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; TUMOR CELL; TUMOR GROWTH; UTERUS MYOMA;

ANIMALS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; LEIOMYOMA; RATS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 33745567558     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.12.049     Document Type: Article

References (22)

1. Healy D.L., Lawson S.R., Abbott M., Baird D.T., and Fraser H.M. Toward removing uterine fibroids without surgery. subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase. J Clin Endocrinol Metab 63 (1986) 619-625
2. Maruo T., Ohara N., Wang J., and Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 10 (2004) 207-220
3. Yue W., Santen R.J., Wang J.P., Li Y., Verderame M.F., Bocchinfuso W.P., et al. Genotoxic metabolites of estradiol in breast. potential mechanisms of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 86 (2003) 477-486
4. Reddy V.V., Hanjani P., and Rajan R. Synthesis of catechol estrogens by human uterus and leiomyoma. Steroids 37 (1981) 195-203
5. Creveling C.R. The role of catechol-O-methyltransferase in the inactivation of catecholestrogen. Cell Mol Neurobiol 23 (2003) 289-291
6. Howe S.R., Gottardis M.M., Everitt J.I., Goldsworthy T.L., Wolf D.C., and Walker C. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol 146 (1995) 1568-1579
7. Al-Hendy A., Lee E.J., Wang H.Q., and Copland J.A. Gene therapy of uterine leiomyomas. adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol 191 (2004) 1621-1631
8. Xie T., Ho S.L., and Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56 (1999) 31-38
9. Sambrook J., Fritsch E., and Maniatis T. Detection and analysis of proteins expressed from cloned genes. In: Ford N., Nolan C.F.M., and Ockler M. (Eds). Molecular cloning-a laboratory manual (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 18-79
10. Cavalieri E.L., Rogan E.G., and Chakravarti D. Initiation of cancer and other diseases by catechol ortho-quinones. a unifying mechanism. Cell Mol Life Sci 59 (2002) 665-681
11. Amant F., Huys E., Geurts-Moespot A., Lindeque B.G., Vergote I., Sweep F., et al. Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels. J Soc Gynecol Investig 10 (2003) 105-109
12. McLeod H.L., Fang L., Luo X., Scott E.P., and Evans W.E. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. J Pharmacol Exp Ther 270 (1994) 26-29
13. Al-Hendy A., and Salama A. Catechol-O-methyl transferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig 13 (2006) 136-144
14. Bradlow L.H. 2-Hydroxyesterone. the "good" estrogen. J Endocrinol 150 (1996) S259-S265
15. Vandewalle B. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 61 (1989) 239-246
16. Banerjee S.N., Sengupta K., Banerjee S., Saxena N.K., and Banerjee S.K. 2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha. a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells. Neoplasia 5 (2003) 417-426
17. Liu Z.-J., and Zhu B.T. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J Steroid Biochem Mol Biol 88 (2004) 265-275
18. Paquette B., Bisson M., Baptiste C., Therriault H., Lemay R., and Cantin A.M. Invasiveness of breast cancer cells MDA-MB-231 through extracellular matrix is increased by the estradiol metabolite 4-hydroxyestradiol. Int J Cancer 113 (2005) 706-711
19. Inoue K., and Creveling C.R. Induction of catechol-O-methyltransferase in the luminal epithelium of rat uterus by progesterone. inhibition by RU-486. Drug Metab Dispos 23 (2003) 430-432
20. Dynarowicz I., and Watkowski T. Influence of estradiol-17 beta and progesterone on catechol-O-methyltransferase and monoamine oxidase activities in uterine artery and myometrium of ovariectomized pigs. Arch Vet Pol 33 (1993) 29-37
21. Maruo T., Matsuo H., Shimomura Y., Kurachi O., Gao Z., Nakago S., et al. Effects of progesterone on growth factor expression in human uterine leiomyoma. Steroids 68 (2003) 817-824
22. Kurachi O., Matsuo H., Samoto T., and Maruo T. Tumor necrosis factor-alpha expression in human uterine leiomyoma and its down-regulation by progesterone. J Clin Endocrinol Metab 86 (2001) 2275-2280